Search Results 1061-1070 of 21218 for Informed consent

1. Evaluate The Continued Safety And Performance Of The Foot And Ankle Products - Mayo Clinic

   Subject or subject's representative signed informed consent and assent, when applicable, and is willing and able to comply with all study requirements.

2. The Road to Wellness after Breast Cancer - Mayo Clinic

   Willling to sign informed consent. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

3. A Study to Assess Temporal Changes in Reintervention Rate and the Impact of Reinterventions after Endovascular Aortic Repair (EVAR) - Mayo Clinic

   Inability or refusal to give informed consent by the patient or a legally authorized representative. Pregnant or breastfeeding. Life expectancy < 2-years ...

4. Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET) - Mayo Clinic

   Willing to sign and date informed consent document for study participation. 3. Participant is undergoing the Cardiopulmonary Exercise Test (CPET) as ...

5. A Study to Assess Transfusion Requirements in Cardiac Surgery - Mayo Clinic

   Informed consent obtained; Preoperative European System for Cardiac Operative Risk Evaluation (EuroSCORE I) of 6 or more. Exclusion Criteria. Unable to receive ...

6. Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL - Mayo Clinic

   Signed informed consent has been obtained. Subject is at least 21 years of age. Diagnosis of mycosis fungoides (MF) or Sezary syndrome (SS) will be based on ...

7. Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients with Evidence of Systemic Mast Cell Activation (MCA) - Mayo Clinic

   Written informed consent. Age ≥ 18 years. Presenting with at least one of the three criteria below as evidence of systemic MCA: Involvement of 2 or more ...

8. Golden Calf Trial - Mayo Clinic

   Ability to provide written informed consent. Exclusion Criteria. Any of the following because this study involves an investigational agent whose genotoxic ...

9. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

   Patients between the ages of 6 and 65 at the time of signing Informed Consent or Assent are eligible for the study. Patients must be obese, defined as BMI ...

10. Long Term Extension Trial of Setmelanotide - Mayo Clinic

    For patients who qualify and consent, the study will start ... understand and sign the written informed consent/assent, and comply with the trial